Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01937715
Title A Study Of PF-05212384 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI In Metastatic Colorectal Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Pfizer
Indications

colorectal cancer

Therapies

Bevacizumab

Gedatolisib

Fluorouracil + Irinotecan + Leucovorin

Age Groups: adult
Covered Countries USA | CAN

Additional content available in CKB BOOST